WCLC 2025 - Posters & ePosters-P3.18.73 A Phase 1b/2 Study of Gocatamig and Ifinatamab Deruxtecan for Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

P3.18.73 A Phase 1b/2 Study of Gocatamig and Ifinatamab Deruxtecan for Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Asset Subtitle

Pedro Rocha

Meta Tag

Speaker Pedro Rocha

Topic Clinical Trials in Progress